Tumor Uptake of (64)Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

The goal of this study was to characterize the relationship between tumor uptake of (64)Cu-DOTA-trastuzumab as measured by PET/CT and standard, immunohistochemistry (IHC)-based, histopathologic classification of human epidermal growth factor receptor 2 (HER2) status in women with metastatic breast c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Nucl Med
Autors principals: Mortimer, Joanne E., Bading, James R., Park, Jinha M., Frankel, Paul H., Carroll, Mary I., Tran, Tri T., Poku, Erasmus K., Rockne, Russell C., Raubitschek, Andrew A., Shively, John E., Colcher, David M.
Format: Artigo
Idioma:Inglês
Publicat: Society of Nuclear Medicine 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5750523/
https://ncbi.nlm.nih.gov/pubmed/28637802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193888
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars